AIMP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.291200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.532400E-01
Normal-vs-Stage2
8.730600E-01
Normal-vs-Stage3
6.438200E-01
Normal-vs-Stage4
5.167000E-01
Stage1-vs-Stage2
3.134600E-01
Stage1-vs-Stage3
2.108600E-01
Stage1-vs-Stage4
9.248200E-01
Stage2-vs-Stage3
3.158200E-01
Stage2-vs-Stage4
3.414800E-01
Stage3-vs-Stage4
2.949400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.351400E-01
Normal-vs-AfricanAmerican
7.306000E-01
Normal-vs-Asian
8.810000E-01
Caucasian-vs-AfricanAmerican
7.314400E-01
Caucasian-vs-Asian
8.950600E-01
AfricanAmerican-vs-Asian
7.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.537000E-01
Normal-vs-Female
7.953200E-01
Male-vs-Female
7.937000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.805200E-01
Normal-vs-Age(41-60Yrs)
4.705000E-01
Normal-vs-Age(61-80Yrs)
9.911800E-01
Normal-vs-Age(81-100Yrs)
7.364000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.888800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.699000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.543600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.256000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.322200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.210400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.706600E-01
Normal-vs-Daily Drinker
9.061400E-01
Normal-vs-Weekly Drinker
8.607200E-01
Normal-vs-Occasional Drinker
3.150400E-01
Normal-vs-Social Drinker
7.870800E-01
Non Drinker-vs-Daily Drinker
3.863200E-01
Non Drinker-vs-Weekly Drinker
8.448800E-01
Non Drinker-vs-Occasional Drinker
8.001100E-03
Non Drinker-vs-Social Drinker
2.871600E-01
Daily Drinker-vs-Weekly Drinker
5.982400E-01
Daily Drinker-vs-Occasional Drinker
7.990100E-02
Daily Drinker-vs-Social Drinker
8.101400E-01
Weekly Drinker-vs-Occasional Drinker
4.242400E-02
Weekly Drinker-vs-Social Drinker
4.577400E-01
Occasional Drinker-vs-Social Drinker
1.445550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.803800E-01
Normal-vs-Grade 2
5.898200E-01
Normal-vs-Grade 3
5.624200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.672400E-01
Grade 1-vs-Grade 3
2.404200E-01
Grade 1-vs-Grade 4
2.803800E-01
Grade 2-vs-Grade 3
4.248000E-01
Grade 2-vs-Grade 4
5.898200E-01
Grade 3-vs-Grade 4
5.624200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.203800E-01
Normal-vs-NonDiabetic
7.418600E-01
Diabetic-vs-NonDiabetic
3.070000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.732000E-01
Normal-vs-NoPancreatitis
9.108200E-01
Pancreatitis-vs-NoPancreatitis
1.948000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.817000E-01
Normal-vs-N1
9.342400E-01
N0-vs-N1
6.482000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.695440E-01
Normal-vs-TP53-NonMutant
7.441400E-01
TP53-Mutant-vs-TP53-NonMutant
1.196170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
